Evidence map›Paper›PMID 38173035›Full record

ArticleBMC chemistry2024

Synthesis, design, biological evaluation, and computational analysis of some novel uracil-azole derivatives as cytotoxic agents.

Leila Emami, Fateme Zare, Soghra Khabnadideh, Zahra Rezaei, Zahra Sabahi, Saman Zare Gheshlaghi, Marzieh Behrouz, Mina Emami, Zahra Ghobadi, Sedighe Madadelahi Ardekani and 3 more

Abstract read
In one paragraph

Article in BMC chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Design, synthesis,Frontiers in chemistry · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Leila Emami *Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Fateme Zare *Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. of Iran.
Soghra KhabnadidehPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra RezaeiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra SabahiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. of Iran.
Saman Zare GheshlaghiDepartment of Chemistry, Computational Quantum Chemistry Laboratory, University of Sistan and Baluchestan, Zahedan, Iran.
Marzieh BehrouzDepartment of Chemistry, Shiraz University of Technology, Shiraz, Iran.
Mina EmamiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zahra GhobadiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. of Iran.
Sedighe Madadelahi ArdekaniPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh BarzegarPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ali EbrahimiDepartment of Chemistry, Computational Quantum Chemistry Laboratory, University of Sistan and Baluchestan, Zahedan, Iran.
Razieh SabetDepartment of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, I.R. of Iran. sabet_r@sums.ac.ir.

Funding

Shiraz Transplant Research Center, Shiraz University of Medical Sciences 18673
6 · The paper itself

Abstract

The design and synthesis of novel cytotoxic agents is still an interesting topic for medicinal chemistry researchers due to the unwanted side effects of anticancer drugs. In this study, a novel series of uracil-azole hybrids were designed and synthesized. The cytotoxic activity, along with computational studies: molecular docking, molecular dynamic simulation, density functional theory, and ADME properties were also, evaluated. The compounds were synthesized by using 3-methyl-6-chlorouracil as the starting material. Cytotoxicity was determined using MTT assay in the breast carcinoma cell line (MCF-7) and Hepatocellular carcinoma cell line (HEPG-2). These derivatives demonstrated powerful inhibitory activity against breast and hepatocellular carcinoma cell lines in comparison to Cisplatin as positive control. Among these compounds, 4j displayed the best selectivity profile and good activity with IC

Indexed as

ADMEDFTMolecular dynamics simulationUracil-azole hybrids

Identifiers

PMID38173035
PMCPMC10765869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.